Philips' RADIQAL Study: Revolutionizing Coronary Procedures with Ultra-Low Dose X-ray Technology

ADVERTISEMENT
2025-05-20
Philips' RADIQAL Study: Revolutionizing Coronary Procedures with Ultra-Low Dose X-ray Technology
The Manila Times

Philips Healthcare is pioneering a new era in cardiovascular care with the launch of the RADIQAL (Reducing Angiographic Dose with Intelligent Quantification and Low Dose) study. This groundbreaking initiative aims to gather real-world evidence demon ...Read more

Recommendations
Recommendations